Evidence map›Paper›PMID 36766748›Full record

ArticleCells2023

Modulation of Kinase Activities In Vitro by Hepatitis C Virus Protease NS3/NS4A Mediated-Cleavage of Key Immune Modulator Kinases.

Mohd Amir F Abdullah, Sarah M McWhirter, Zucai Suo

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Mohd Amir F AbdullahDepartment of Biochemistry, The Ohio State University, Columbus, OH 43210, USA.
Sarah M McWhirterDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA.
Zucai SuoDepartment of Biochemistry, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0003-3871-3420
Florida State University · USHarvard University · USThe Ohio State University · US

Funding

Investigation of DNA base excision repairR01GM122093 · NIGMS · FLORIDA STATE UNIVERSITY · PI SUO, ZUCAI · 2018 to 2021
$1.2M
National Institute of Health R01GM122093National Science Foundation MCB-1716168NIGMS NIH HHS R01 GM122093
6 · The paper itself

Abstract

Hepatitis C Virus NS3/NS4A, a serine protease complex, has been found to interact with many host proteins and cause various adverse effects on cellular function and immune response. For example, the cleavage of important immune factors by NS3/NS4A has been suggested as a mechanism for the hepatitis C virus to evade innate immunity. The spectrum of susceptible substrates for NS3/NS4A cleavage certainly includes important immune modulator kinases such as IKKα, IKKβ, IKKε, and TBK1, as demonstrated in this paper. We show that the kinase activities of these four host kinases were transformed in unexpected ways by NS3/NS4A. Treatment with NS3/NS4A caused a significant reduction in the kinase activities of both IKKα and IKKβ, suggesting that HCV might use its NS3/NS4A protease activity to deactivate the NF-κB-associated innate immune responses. In contrast, the kinase activities of both IKKε and TBK1 were enhanced after NS3/NS4A treatment, and more strikingly, the enhancement was more than 10-fold within 20 min of treatment. Our mass spectroscopic results suggested that the cleavage after Cys89 in the kinase domain of IKKε by NS3/NS4A led to their higher kinase activities, and three potential mechanisms were discussed. The observed kinase activity enhancement might facilitate the activation of both IKKε- and TBK1-dependent cellular antiviral pathways, likely contributing to spontaneous clearance of the virus and observed acute HCV infection. After longer than 20 min cleavage, both IKKε- and TBK1 gradually lost their kinase activities and the relevant antiviral pathways were expected to be inactivated, facilitating the establishment of chronic HCV infection.

Indexed as

Hepatitis CI-kappa B KinaseAntiviral AgentsHepacivirusHumansProtein Serine-Threonine KinasesSerine ProteasesViral Nonstructural ProteinsAntiviral AgentsI-kappa B KinaseProtein Serine-Threonine KinasesSerine ProteasesViral Nonstructural ProteinsHCV proteaseIKKα, IKKβ, IKKε, TBK1kinase regulatory domain

Identifiers

PMID36766748
PMCPMC9913602
OpenAlexW4317932000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.